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Abstract 
This final letter report summarizes activities conducted by C-Med in developing a 
business plan for commercializing the Electronic HouseCall (EHC) system. Whereas the initial 
goal was to develop a formal business plan that could be presented to interested companies in the 
July '97 timeframe, the results of early efforts required that the focus of C-Med's activities be 
redirected. As a result, the role of C-Med became one of managing the interests of 23 companies 
desiring to license the technology and ultimately coaching finalists in submitting an offer. 
The project was extended on two occasions such that the period of performance was from 
January 20, 1997 through October 31, 1997. The program resulted in the formation of 
CyberCare, Inc., a Georgia-based start-up company, as the commercial partner to bring the EHC 
technology to market. 
Program Description 
The initial program was established to allow the Georgia Institute of Technology (GIT) 
and the Medical College of Georgia (MCG) to retain a consultant to develop a business plan for 
commercializing the EHC technology. Both institutions contributed half the funding necessary 
to contract with C-Med Corporation to perform services defined in the Statement of Work. Mr. 
Tony Jatcko, President of C-Med Corporation, directed activities conducted by C-Med under this 
contract. 
The initial statement of work required that C-Med work with and under the direction of 
the resources at GIT and MCG to develop a business plan for the potential commercial 
capitalization of the jointly owned technology application developed under the EHC project. 
The resultant business plan was to serve as a tool for attracting a commercial entity or to 
facilitate the formation of a start-up company to refine and market the EHC system. The work 
proposed under this contract was to be carried out in four phases. 
The first phase involved initial planning and preparation of a preliminary business 
prospectus. The planning efforts focused on defining the current status of the EHC system from 
a technical, financial, and intellectual property standpoint. In addition, background work was 
conducted in consultation with both universities to determine what the universities wanted in 
return for an exclusive license to the technology. Once the universities determined what they 
wanted for the technology, a complete business prospectus was developed (Appendix A). The 
prospectus included a basic business overview, description of potential markets, definition of the 
products and services, projected target financials, and suggested potential relationships with the 
commercial partner. The prospectus was used as the initial presentation materials and 
information for aligning the external communities of interest, prior to having a finished business 
plan. As a result of feedback from various potential partners, the business prospectus was 
modified to project a consortium approach to establishing a new Georgia-based company 
(Appendix B). 
The second phase involved researching the business plan content. Activities centered 
around gathering the information and details necessary as content to a thorough business plan, 
socializing the opportunity to and aligning the appropriate external communities of interest and 
markets, and finalizing the costing and overall product and/or services plan, integrations, design 
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and schedules. Phase 3 and 4 of the initial statement of work was redefined as a result of the 
interest obtained from potential commercial partners after the first two phases had been 
completed. Therefore, C-Med did not develop a formal business plan, but their activities were 
redirected to socializing the opportunity with the 23 interested companies. A list of prospective 
commercial partners, as of June 5, 1997, is provided in Appendix C. 
C-Med pursued the commercial business relationships until the end of the initial contract 
on June 30, 1997. It was apparent that there was a strong potential of securing a commercial 
partner as a result of activities conducted since January 20; however, the process of selecting a 
single partner had not been concluded. As a result, the contract with C-Med was extended for 
two months with a new statement of work consisting of two tasks. The first task involved 
securing best and final offers from the potential commercial partners and providing 
recommendations to the administrations regarding selecting a single partner. The second task 
involved completion of a formal business plan that could be used as the basis for a Georgia-
based start-up company. The goal of the second task was to develop an alternative commercial 
avenue should all offers from existing interested companies prove unacceptable. Since the 
response from requests for final offers appeared promising, C-Med focused its attention on 
nurturing those relationships rather than developing a formal business plan. 
A letter requesting best and final offers from the 23 potential partners was prepared and 
mailed in July (Appendix D). It established a deadline of August 1, 1997 by which the 
universities expected to be in a position to make a decision regarding a commercial partner. Two 
of the original 23 interested companies responded with a best and final offer; however, each offer 
was sufficiently vague as to require follow-up to clarify a number of outstanding issues. In the 
meantime, a local group of executives comprising The Willow Group assembled a team to 
respond to the opportunity to commercialize the technology. As a result, there were three viable 
offers to license the EHC technology from the universities. 
After considerable due diligence to clarify the offers fron1 the three potential partners, it 
was determined that a meeting with administrative representatives from GIT and MCG in which 
each potential partner would present their offer would be held on September 18, 1997. Since the 
contract with C-Med was set to expire on August 31, 1997 and there was more work to be done 
in securing a commercial partner, an extension was requested and granted through October 31, 
1997. The objectives of C-Med under the extension were to finalize the meeting on September 
18 with the three finalists, assist them in preparing their presentations, and to finalize the 
partnership with the organization selected as the commercial partner following the meeting. On 
September 18, 1997, representatives from the three final candidates, Thermo Information 
Solutions, Inc., Health Consultants Intemational/NetSpeak, Inc., and The Willow Group, 
traveled to Augusta to present their offer to the GIT and MCG administrations. Following the 
meeting, Dr. Max Stachura and Mr. Michael Burrow provided recommendations to the 
university administrations based on an analysis conducted of each offer. The administrations 
subsequently chose to partner with The Willow Group to form a Georgia-based company and 
commercialize the EHC technology. 
C-Med's activities during the latter half of Septen1ber and during the month of October 
focused on assisting The Willow Group in preparing a business plan and fonnalizing he 
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relationship between GIT, MCG, and The Willow Group. On October 31, 1997, CyberCare, Inc. 
was formed by John Haines, President of The Willow Group, to commercialize the EHC 
technology. GIT and MCG n1aintain a 20% equity position in CyberCare, a 4°/o royalty position 
based on net sales, and research and development funding totaling to $2.1 Million over three 
years. A copy of the final license agreement is provided in Appendix E. 
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INITIAL BUSINESS PROSPECTUS 
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INTRODUCTIONSJ 
PARTICIPANTS 
• Telemedical Center of the Medical 
College Of Georgia 
-Directed by Max Stachura, M.D., with Dr. John 
Searle 
-Formerly Directed by Dr. Jay Sanders, ATA 
President 
-Integral to Georgia Statewide Telemedical Program -
GSTP 
• Biomedical Interactive Technology 
Center of the Georgia Institute of 
Technology 
- GIT- Worldwide Technology Researcher & 
Developer. 
- BITC Projects led by Jim Toler, Mike Burrow & John 
Peifer 
- BITC- R&D in Telemedicine, Surgical Simulation, 
Diagnostic Devices & Medical Robotics 
• Assisted by CMed Corporation 
-Led by Tony Jatcko 
• Combination Provides: 
-Unique Application Level Development with High 
User Focus 
EHC DEFINEEJ 
• Telemedicine System in Product,ive 
Clinical Trial With Proprietary, 
-Integration of Diagnostic Devices -PC Based 
-Multimedia Graphical User Interfaces 
-Administrative/Patient Database 
• Extensive Provisional Patent 
Application Filed 
• Enhances Access - Patients to Care 
Center 
-Interactive Video & Audio 
-6 Critical Vital Signs Diagnostic Interfaces 
-Interactive Storage & Retrieval of Patient & Pro~ider 
Data 
-Guided, High Human Factors Multi Media Integration 
~Diagnostic Measurement & Transmission 
~Usage Training, Instructional/Reference Videos 
-Scheduled or Random Dial-up, by Either End 
-Interactive or Store & Forward Sessions 
EHC DEFINED (Cont.) 
• Application That Promises: 
-Extended Access for Clinical Staff to Point•ef-Care 
Sites 
-Significant Reduction in Per Visit Costs 
-Increased Healthcare Staff Productivity 
-Releases Medical Facilities, Inpatient & Emergency 
Services 
-Better Patient Access to Healthcare 
-Home, Community or Commercial Placements 
• PC Multi Media System, Integrated witt~ Six 
Medical Diagnostic Devices in a Cormfiortable 
Package, Operating under Windows 95, Intel 
Proshare and Utilizing the Proprietary Software, 
Experience and Knowledge of the Resource.s of 
MCG and GIT. 
• Patient Systems have been Deployed in 17 Homes 
& 1 Nursing Home for 25 Patients 
• Monitoring Systems Deployed at MCG Hospital 
and Residence and office of the Medical Director 
of the Nursing Home 
• Deployed in Augusta Area on a LAN Extended· 
"Ethernet" Network over Coax Cable & ISDN, to . 
Ludowici, GA on Basic Rate ISDN 
• Diagnostics Measurements Include: Blood 
Oxygen, Blood Pressure, Heart/Lung Sounds, 
EKG, Weight, Temperature & Pulse 
MARKET'S AVAllABL8 
• Traditional Clinical Outreach to 
Patient Homes 
• Health Service Centers 
-Nursing Homes 
-Industrial Health Centers 
- HMO's 
• Community Monitoring Locations 
-Pharmacies 
-Health/Fitness Centers 
-Malls, Schools, Libraries, Rec. Centers 
-Hotels 
STATE OF THE 
OPPORTUNITY 
• 1 Mil. Patients in Need and 18,500 
Providers Available in 1996 (NAHC 
Data, Traditional Homecare Agencies only) 
-Fastest Growing Telemedical Application (CBO or 
NMES Data) 
- 13°/o CGR or 18.2°/o CGR 
-In 1996- $36 Bil. (Omitting Hospital Based) or $52 
Bil. 
• Why? Many Benefits to Home 
Health Care, Relative to Others! 
-It's Needed! - $400 Bil. costs of Hospital care in 
1996 
-Very Cost Effective Service 
-Humane Compassionate Delivery 
-Supplements Family 
-Maintains Dignity and Independence 
-Patient's Active Role- Team Member 
• Trends in Care Costs? (NAHC) 
-Hospital Day= $1872. 
-Nursing Home Day= $334. 
-Traditional Homecare = $88. 
- Tele-HomeCare = $35, or less. 
TELE-HOME CARE REVIEW 
-LIMITED MARKET STUD'¥ 
• Connecticut 2 year Study of 6QO 
Psychiatric Patients 
- 80.7°/o Could have been Treated at Home 
- 11.97 reduced to 7.48 Days as Inpatient 
- 11.8°/o versus 45.9°/o Readmitted 
• VA Study of Termina_l Ill Vetera:ns 
-Reduced Per Capita Costs by $971 
• COPD Patients 
-Those Admitted Used 5.9 fewer days 
- Overall Cost per Patient Reduced by $328/month 
• Congestive Heart Failure Group 
-Admissions Decreased from 3.3 to 1.2 per Year 
-Average Length of Stay Decreased from 26 to 6 days 
• Cardiovascular Group 
-Admissions Decreased from 2.9 to 0.8 per Year 
-Average Length of Stay Decreased from 23 to 4 days 
COMMERCIAL INITIATIVES I 
LIMITED MARKET STUD) 
• 1996, Successful Roll-out to 40 Patients 
at Helen Ellis Memorial 
• 1996, Program Rolled-out in 
Hays/Lawrence, KS (Reimburse'ment)-
• 1996, CVS Pharmacies/Pfizer Jointly 
Funding 
- VueCom, RTI 
• 1996, Kaiser Permanente, Purchased 200 
American Telecare Units 
• 1997, SNET & VNA HealthCare Hospice, 
Plan 1998 Service, w/HANC 
• 1997, Jay Sanders, Global TelemediciAe 
Group -Forming Consortium 
• etc. 
THE TIME IS RIGHT FOR TELE-HOME CARE 
NEAR TERM TASKS 
REMAINING 
• Commercially Prepare Existing 
Integration for Market 
• Repackage Functions and Software 
- Costs & Market RequiremeRts 
-Modular "Plug & Play" Design 
-Selectable Features, Levels of Capability 
-Scalable Communications 
-Various Kiosk Systems 
• Develop Business Plan, Relative to 
Partner's Direction 
-Focus Efforts 
- Market Surveys 
-Address Reimbursement 
• Develop Business Operational Plan, 
Organize Accordingly 
• Develop Additional Medical 
Diagnostics for Future 
• Continue Formal Clinical Data 
Gathering 
SUGGESTED BUY -IN 
ARRANGEMENT 
To Acquire an Exclusive EHC 
Technology License & On-Going 
Involvement of MCG & GIT Resources 
• Up-Front Fee - $300,000 
• Fund Existing EHC Project Staffs for 
On-Going R&D 
- $2.7 Million over Next Three Years 
- Reduced Funding, as Required, After Three Years 
• On-Going Royalties at 6°/o of Revenues 
Realized 
• 20°/o Stock Equity Position for GI-T 
• Retained Resource, Integral to 
Established Company 
-Represent MCG & GIT Business Interest 
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Note: Based on 1996 Healthcare Industry "Average" Statistic~ 
• 350 million Visits/year @ $80/visit = $28 Billion Ma~rket 
• 50°/o Can be done w/remote Electronic Terminals 
• So! 50°/o of$28 Billion= $14 Billion "in play". 
Electronic Housecalls are "estimated" @ $35/visit. 
• Yields, 50°/o of 350 B. @ $35 = $6.125 B. Service $'s, 
(22°/o). 
• Nets, $14 B. - $6.125 B.== $7.875 B. Savings, (28°/o). 
CLINICS l?OTENTIAL~ 
''A Perspective'' 
• 28°/o Operational Savings over Traditional Calls 
• Or: Focus on Productivity of Electronic Calls .. 
Nurse can do: 15 versus 5 visits/day (on 1/2 the 
patients) 
So? While Maintaining a constant force~ Nurses are 
- Twice as Productive 
- Clinic ''Reaches'' 2X more patients. 




• Traditional: 5/day@ $80 visit== $400/Nurse Day 
• Electronic: 15/day@ $35 visit== $525/Nurse Day 
• Thus: $125/Nurse Day in additional revenue 
Assume: Clinic maintains constant Nurse Revenue, while 
extending reach, then $125/Nurse Day, Available. 
For provider?: 
That's: $32,500/year or $2,708/mo., For each Nurse 
"Or" 
That's: $650,000/year, For a 20 Nurse Clinic 
"Or" 
That's: $14.6 Mil./year, For 1 °/o Market Penetration 
Carrier Usage? 
For 20 nurse Clinic,== $900/day or $19,800/mo. (300 ses./da: 
@ 20 min./ea. @ 15cpm) 
+Additional Usage Applications 
WHAT'S NEEDED~ 
''At This Point - 6/1/97'' 
• Partners- Committed to Fund & Work Jointly. 
• Continuance of Roll-out of EHC Test Beds. 
-Maintain Momentum & P.R. 
- Capture Opportunities 
• Focused Work Period: 
-Finalize "Formal Business Plan". 
-Structure & Capitalize "Newco". 
• Interim Budget - $600K over a Max. 6 mont:h:s. 
-Funds: 
MCG & GIT Continuance. 
Formation of "Newco" -In ATDC 
Resources - Plan, Form and Capitalize 
-Provides: 
4 Month Go/No Go! 
Partner Exclusivity & "First Rights". 
Time For Role Definitions & Assignments. 
Establishment of Equity/Royalty Positions. 
MCG 
'. 
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Business Plan Development B03-629 
APPEDIXC 
LIST OF 23 POTENTIAL PARTNERS 
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Opportunity 
1. Thermo Electron 







9. Bell South 
10 . Hitach1 
11 . G. E. Med Syst. 
12. llnvlcLt-l \ lckarJ 
13 . Tumer TeleCom 
14 . Comp. Dev. Can . 
15. BID 
16. TeleAssist 
17. Pacific Interpreters 
18 . UN Hosp ital 
19. Glohal Telemed 
20. .IJ.lkractivc Mcd 
21. Phizer/CVS 
22 . Raytel Cardiac 
23 . VCom Systems 
6/5/97 Status of EHC Commercialization 
Description of Company 
Large Conglomerent Focused on New Business Developments 
Very Large Health Industry Corporation 
Very Large Japanese Industrial w/Heal thcare Focus/Products 
Atlanta Based Medical Diagnostic Equipment Corporation 
Very large Japanese Industrial, (Panasonic) 
Medical Diagnostic Equipment Company 
Large National Com. Corp. w/Healthcare Focus/Products 
Entrepreneurial Web Tech. Co. tunds by Motorola & Health Org. 
Large Local Communication Corp. w/ Healthcare Interest 
Very large Japanese Industrial 
Large USA Based Industrial w/ Healthcare Bus Units 
Lngc USA Electronic Industrial w/ Heallhcare focus 
New Atlanta Based Network Appl. Business Unit Start-up 
Large Canada Based Supplier of Tech.!Med. Appl. to Military 
Start-up "Business for International Development" w!Med Kiosk 
Start-up Co. w/HouseCall Product 
Small Company Building Language Interpreting Units 
Utah based Hospital Administrator/Entrepreneur, Steven Mabry 
Consortium, Jay Sanders Formed 
Start-up Desktop Telemedical Product Provider 
Joint Corporate Effort, Vuecom Coor, For Medical Monitor Kiosk 
Smaller Medical Device Provider, Considering Remote Monitor 
Small System Integrater Focused on Opthalmology Technologies 
Summary Statistics: 
#of Visits, Meetings &Demo's = 23, (3-4 Hour sessions) 
#of Visits, Meetings & Demo's = 22 (3-4 hour sessions) 
#of Conference Calls w/Team = 8 (1-2 hour Sessions) 
#of Phone Reviews, one-on-one= Numerous 
Results To Date Over 23 Contacts: 
5 - Expect an Offer, (1,4,8,9&7) 
3 - Still Remain Open, Offer Possible, (2,22&23) 
6- Interested Big Orgs, Can't Fund By 7/1, (3,5,10,12,13&14) 
4- Interested Smaller Orgs. w/Limited Funds, (15,16,18,&20) 
5- Limited Interest at this Point, (6,11,17,19&21) 
Status/Outcome as of 6/5/97 
Many Mtgs, Made 1st Offer on 5/30/97, Requesting resubmittal 
Intra Mtg, Short Time Problem I Requesting Final Chance 
I.ntro Mtg, Can't Do/Timing Problem, Interested I Keep in Touch 
Multiple Mtgs , Joint Planning, Offer Mtg. Scheduled, 6/4/97 
Intra Mtg, Can't Do/Timing Problem I Keep in Touch 
Intra Mtg I No "System" Strategy I Remain a Device Supplier 
Intro Mtgs. I Feedback Positive I Offer Pending 
Multiple Mtgs I Very Interested I Expect offer by 6/5/97 
Multiple Calls I Review mtg. on 5/28/97 I Expect Offer 6/5/97 
lntro Mtg I Limited Interest I No Follow-up Needed 
Stachura Intro, No Follow-up Contacts thereafter 
Toler Intro , F-up w/many Phone Calls, Interested, b/Timing Bad 
Jatcko Intro & Demo, Interested b/Bad Timing for Funds 
Multiple Calls, Interested b/Timing Not Possible 
Intro Mtg, Interested in Joint Venture, Time/Seek Funds Minimal 
Intra Mtg, Many Calls, Interested, b/No Add'l Funds Available 
Multiple Calls, Interest in Multi-Media Interface, b/No Funds 
Multiple Calls, Interest in Promoting and Developing, b/No Funds 
Conf. Attendance , Limited Interest, Will produce Their Own Unit 
lntro Mtg, Multiple Calls, No Funds to Incorporate EHC Tech. 
Demo Visit, Mult Calls, No Response to Inquiry Memo 
Phone I.ntro , Reviewing Info , No Response Back Yet 
Phone Intra, materials sent, Interested in Sub license, if available 
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LETTER REQUESTING BEST AND 
FINAL OFFERS FROM THE THREE 
FINALISTS 
Georgia Institute of Technology Biomedical Interactive Technology Center 
July 15, 1997 
Mr. John Doe 
President 
XYZ Company 
Anywhere, GA 12345 
Dear Mr. Doe, 
The Georgia Institute of Technology (GIT) and Medical College of Georgia (MCG) are 
entering into their final evaluation phase of the opportunity to commercialize the 
Electronic Housecall Technology. This letter is intended to clearly and consistently 
communicate our time-line for this decision, to reiterate our offer, as well as update you 
on our alternatives at this point. We enjoyed discussing this commercialization 
opportunity with you and hope that we will be working together in the future to capitalize 
on this exciting market opportunity. 
We are requesting from all interested parties that final offers be submitted no later than 
August I st, 1997. This will permit our scheduled final presentation to the University 
Presidents during the following week of August 4th-8th, 1997. It is recommended that 
preliminary offers be faxed orE-mailed to CMed Corporation by July 25, 1997 to allow 
GIT and MCG representatives to review the documents and clarify issues that the 
University Presidents are likely to raise. Addressing these issues before the meeting will 
allow us to represent your organization in the best possible light. 
We have made every attempt to consistently and fully communicate our offer to all 
candidates interested in the EHC technology during this commercialization project. To 
clearly restate: Our original request for $3 million funding over 3 years plus 20o/o equity 
and 6o/o royalties for full rights to the EHC technology has not changed, but has been 
modified to include, if required, an up-front final business crafting period of 6 months at 
an initial funding level of $500,000. This initial funding will allow the GIT/MCG team 
to maintain their momentum from both a clinical and technical perspective while 
"NewCo" is being capitalized. Upon successfully establishing capitalization for the 
anticipated formally and fully planned "NewCo," a commitment to provide the balance of 
$2.5 million, plus equity and royalties would still be required for full transfer of the EHC 
property rights to "NewCo." 
At this point, I, working with the established GIT/MCG team, anticipate presenting 5 
alternative directions for Executive decision, with our corresponding recommendations. 
Our 5 present alternatives include 3 separate, external corporate candidates who wish to 
acquire full, exclusive manufacturing/distribution licensing for the EHC technology and 
also 6 candidates who would consider a secondary sub-licensing arrangement with our 
selected partner conunercializing EHC, at a later date. 
Our 4th alternative is to fully develop the business plan, for which I was originally hired 
by GIT/MCG, and form a "NewCo" here in Atlanta, with Atlanta based technical and 
1nanagerial resources and funded via local venture capital sources. This alternative has 
become a possibility based on interest expressed by the local health care community and 
local funding sources. 
The 5th alternative, which has evolved over the course of this project, is for GIT/MCG to 
simply license copyrighted versions of the EHC software. Recent funding potentials and 
advances in the EHC technology have made this a viable alternative. A favorable 
anticipation of being granted an award for full funding to participate in the Federal 
Governn1ent's NIST Advanced Technology Program, which is focused on developing 
comn1ercialized home healthcare products, would allow us to pursue this option. 
In any event, we have enjoyed specifically working with you and wish sincerely to 
maintain an on-going relationship with you and the assets you represent. Georgia Tech 
and the Medical College of Georgia are leaders in telemedicine as part of an unequaled 
Statewide Telemedical Network and an application development effort that certainly may 
have other technologies of interest to you. 
Thank you! 
Best regards, 
Tony Jatcko, CMed President 
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THIS AGREEMENT is made and entered into the 1' 1l day of ..I)a.c.L.._~ , 
1997 (hereinafter "Effective Date") by and between the GEORGIA TECH RESEARCH 
CORPORATION, a nonprofit corporation organized and existing under the laws of the State of 
Georgia and having its principle offices at the Georgia Institute of Technology (hereinafter "GIT"), 
Centennial Research . Building,- Atlanta,·. Georgia 30332-0415,-- (hereinafter · ~GTRC") and 
CYBERCARE, INC., a corporation existing under the laws ofthe State of Georgia and having its 
principle offices at 430 Tenth Street, N.W., Suite S-004, Atlanta, Georgia 30318 (hereinafter 
"CYBERCAREt1). 
- ~I INES .S E I H: 
WHEREAS certain employees of the Georgia Institute of Technology and the Medical 
College of Georgia (MCG) have collaborated in creating an invention knovm as the "Electronic 
House Call: A Telemedicine System for Monitoring theHeaJth of Patients in Their Homes", which 
is the subject GTRC Invention Disclostire Number 1798 and Software Disclosure Number 1810, and 
U.S, Patent Application Number 08/934;,442 (hereinafter "Invention"); and 
WHEREAS said employees have assigned all their right, title and interest in the Invention 
to GTRC and the Medical College of Georgia Research Institute (MCGRI) respectively~ and 
\\'HEREAS GTRC and MCGRI have available to them certain know-how, technology, trade 
secrets and methoes (hereinafter "Know-How") wruch relate to the Invention; and 
WHEREAS by Agreement dated October 13, 1997, a copy ofwhich is attached as Exhibit 
"A" to this Agreement, GTRC and MCGRl (the ''Joint 0"Wners") agreed that GTRC would act on 
behalf of the Joint Owners in pursuing intel1ectuaJ property protection and commercialization of the 
Invention and Know-How related to the Invention (hereinafter "Technology"); and 
WHEREAS CYBERCARE wishes to utilize the Techno1ogy to adueve the development, 
manufacture, use and sale of Products containing the Techno1ogy; and 
NOW, THEREFORE, GTRC and CYBERCARE in consideration of the foregoing and the 
mutual promises contained herein and intending to be legally bound hereby agree as follows : 
1. DEFINITIONS 
As used herein: 
1.1 "Net Selling Price'' shall mean the gross sales by CYBERCARE or any approved 
sub]jcensee of the Products, less only installation charges, usual trade discounts, sales 
tax which the seller has to pay or absorb, customs duties and transportation and 
-1-
insurance charges, if not included in the gross price, and any and all Federal, foreign, 
State or local taxes (except income tax) incurred by the seller on such sales. 
1.2 t1Patentt1 shall mean any issued letters patent disclosing and daiming the Invention, 
including a reissued patent, a patent issuing from a continuation application, divisional 
application or continuation-in-part application, and means any foreign patent similar 
thereto. 
1.3 . "'J;>rod~~s~ shall .m~ any system or, equipme~t incorporating the Techn.ology..(a 
"System") through which the Technology is commercialized and utilized by 
CYBERCARE, but shall not include any peripheral equipment, devices or other 
products (collectively, "Ancillary Products") not regularly incorporated in the 
standard operating unit of the System as offered for sale by CYBERCARE, whether 
or not the Ancillary Product is located vvithin the same container, shell, cover or other 
housing in whkh the standard operating unit resides. 
1.4 "Sales", "Sell, or "Sold" shall .mean any sale, transfer, lease, license, rental, fee for 
service, permission to use or other transfer of the right of possession or other 
conveyance by CYBERCARE or any approved sublicensee. 
1.5 "Sales Made~' shal1 mean Sales for which payment has been received by 
CYBERCARE. 
1.6 "Proprietary Information" shall mean information and trade secrets owned or 
controlled by GTRC and MCGRl at any time during the term of thls Agreement, 
which relates to the Inventions covered by the licensed Patents, including but not 
lim1ted to, invention records, research records and reports, engineering and techrucal 
data, designs, production specifications, processes, methods, procedures, facilities and 
know-how. 
1. 7 · "Tenitory" shall mean the world . 
2. GRANT OF LICENSE 
2.1 With respect to the Technology to which GTRC and MCGRI have exclusive rights, 
GTRC, acting on behalf of the Joint Owners, hereby grants to CYBERCARE an 
exclusive, nontransferable, royalty-bearing license, with a right of sublicense, to make, 
have made, sell, and use Products throughout the Tenitory. CYBERCARE shall not 
export any Product or enter into any sublicense without ful1y and completely 
complying with any and aJJ United States export or munitions control regulations and 
laws . 
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2.2 Any provision of this Agreement to the contrary notwithstanding, GTRC and MCGRJ 
reserve an irrevocable, nonexclusive, royalty-free, nontransferable license to make and 
use the Technology for educational and research and development activities practiced 
by GTRC, GIT, MCG and MCGRJ. 
3. CONSIDERATION 
3.1 . I~ . C()nsid~tiqn . of the.· granting herein of the License a5 described in · Article 2, · · 
CYBERCARE.shall: 
3 .1.1 Pay GTRC and MCGRI, collectively, the sum of Two :Million One Hundred 
Thousand U.S. DolJars ($2, 1 00,000) during the three years following the 
Effective Date of this Agreement, in the manner and subject to offsets detailed 
in Article 10 herein~ and 
3.1.2 Pay GTRC the Royalties as set forth below in Article 5; and 
3 .1.3 As additional consideration for the License granted herein, CYBERCARE 
shall i5Sll~. ~o .OJRC 81lQ :MC.GR.lasufficient number of shares ofits·common 
stock s~ · that GTRC and MCGRl will each own Ten percent (10%) of the 
total number of shares issued. Upon initial issuance and thereafter until 
infusion of total capital from eight (8) million shares sold to investors or 
comrrlitted to lenders, a proportionate number of shares shall be issued to 
GTRC and MCGRl so that their Ten percent (1 00/o) ovmership interest each 
in CYBERCARE shall be maintained . If additional shares are sold for cash 
thereafter, GTRC and MCGRI shall be given the opportunity to purchase 
additional shares at the same price as the new shares being sold, such that each 
may maintain their Ten percent (1 0%) ownership . 
3.2 Simultaneously with the execution of this Agreement, CYBERCARE, GTRC and 
MCGRI will enter into a SharehoJders Agreement in substantially the form attached 
hereto as Ex.hlbit "B". 
4. SUBLICENSE 
4.1 Subject to this Paragraph, CYBERCARE may grant sublicenses to persons or entities 
specifically approved in writing by GTRC, wruch approval shall not be unreasonably 
Vlithheld, provided that each sublicense contains a provision that such sublicense and 
the rights thereby granted are personal to the sublicensee thereunder and such 
sublicense cannot be funher assigned or sublicensed 
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4.2 Any sublicense granted pursuant to this Article shall be in accordance with the terms 
and conditions of this Agreement and shall at a minimum, contain the same protection 
for the Joint Owners' Proprietary Information as is set forth herein. 
4. 3 In respect of any sublicense granted by CYB ERCARE in accordance with this Article, 
CYBERCARE shall promptly pay to GTRC an amount equal to Thirty percent 
(30%) of any lump sum or other upfront consideration, made by the sublicensee 
thereunder in consideration for the grant of such sublicense to it by CYBERCARE. 
No suchlump sum or other upfrcmt consid~ration sllall be included in Sales Made for 
pUrposes· of this Agreement, and CYBERCARE shall not be required to pay GTRC 
any roya1ties pursuant to Article 5 of this Agreement on such a lump sum or other 
up front payment . 
5. ROYALTIES 
5.1 For the_ tenn oftrus Agreement, CYBERCARE shaJlpay GTRC royalties for Sales 
Made at the rate ofFourpercent {4%) ofthe N~ Selling Price of Products sold by 
CYBERCARE or any sublicensee under this Agreement. This roya1ty rate is based 
on a projected annual total gross profit on gross sales ("taxable income") for 
C:YBERCAREofThirty percent (30%) before :F,eq~ral anci . stategoyemm~nttaxes ,_ 
: It \Vill be. reViewed annually and adjusted up or dovro as appropriate to maintain this 
proportion to actuaJ totaJ gross profit This new rate shall then apply for Sales Made 
during the folloVJing year with a minimum rate of zero (0) . For example, if the annual 
total gross profit of C'YBERCARE before Federal and state taxes for any year is 
forty-five percent ( 4 5°/o ), the royalty rate for the following year would be Six percent 
(6%) ofNet Selling Price, wruch is equaJ to One Hundred Fifty percent (150%) of the 
base royalty rate of four percent (4%) . 
5.2 All payments to GTRC under this Agreement shall be made in U.S. dollars at GTRC's 
address for notice. Such payments shall be prud to GTRC annually on a calendar year 
basis. Payment for Sales Made during each calendar year shall be made to GTRC 
within thirty (30) days after the last day of each calendar year . 
5.3 CYBERCARE shall pay all royalties due hereunder to GTRC and GTRC shall not be 
required to look to any other entity for payment. 
6. ACCOUNTS 
6.1 Not later than March 1 of each calendar year CYBERCARE shall furnish to GTRC 
a statement showing the total net Sales Made of Products by CYBERCARE during 
the immediate preceding caJendar year, and the royalties payable thereon calculated 
in the manner required in Article 5. 
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6.2 CYBERCARE shall keep at its usual place of business true and particular accounts 
of all matters connected with the use of the Techno1ogy and the manufacture and sale 
of all Products and s.halJ keep books of account relating to royalties payable hereunder 
comaining true entries complete in every particular as may be necessary or proper for 
enabling the amount of such royalties to be conveniently ascertained. 
6.3 If requested in writing by GTRC, CYBERCARE shall at all reasonable times produce 
evidence of the matters referred to in Article 6 and shall permit such evidence to be 
. verified . by ~independent acco~:nt~t to be select¢ ~d paid for. by GntC. 
CYBERCARE ·shall give such · acWuntant all n.ecessary facilities for verifying such 
evidence and shall give such information as may be necessary or proper to enable the 
amount of the royalties to be verified. 
7. IMPROVEMENTS 
7.1 Should CYBERCARE or any consultant or employee of CYBERCARE during the 
term of this Agreement make or discover any u,t1provement in connection 'With the 
Technology, whether patentable or not, which if practiced wol)ld constitute an 
infringement of any Patent, CYBERCARE shall forthwith disclose or cause the 
same to be ~i~closed tq YTR~, apd .such imprpvem~nt shaH be deemed to bea .part 
of the ·"Technology" and sha11 be subject to the terms hereof for the purpose of 
caJculating royalties hereunder. The foregoing notwithstanding, CYBERCARE shall 
O\VTl all right, title and interest in any such discovery or improvement. However, 
CYBERCARE shall make available to GTRC and GIT any improvements or 
modifications it makes to the Technology and grants to GTRC, GIT, MCGRI, and 
MCG an irrevocable, non-exclusive, royalty-free, non-transferable license to use the 
improvements throughout the world for educational and research and development 
purposes only . If so requested by GTRC, CYBERCARE shall make available or 
supply to GTRC and MCGRI such information or data as is necessary or converuent 
for the proper understanding or use of such discovery or improvement. 
7.2 If GTRC or MCGRl makes or discovers any improvement to the Technology that is 
developed solely by one or more of the inventors as shown in U.S. Patent Application 
Number 08/934,442, whether patentable or not, wruch if practiced would constitute 
an infringement of any Patent, GTRC and MCGRl shall, subject to the pre-existing 
rights of any third party, forthvvith disclose or cause the same to be disclosed to 
CYBERCARE and such improvement shall be deemed to be included in the term 
"Technology" and to be included in this Agreement and be subject to the tenns hereof 
and any application for ]etters patent or other equivalent protection made in respect 
thereof shall be treated as if it were included in the term "Patent". The costs of 
prosecuting such applications for letters patent or equivalent protection and 
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maintaining the letters patent issuing from such applications &hall be borne by 
CYBERCARE during the tenn of this agreement. Any such discovery or 
improvement shall belong to and be the wle and exclusive property of GTRC or 
MCGRI. 
7.3 lfGTRC or MCGRI makes or discovers any improvement to the Technology that is 
developed other than solely by one or more of the inventors as shovm in U.S. Patent 
Application Number 0&/934,442, ~patentable or not, which if practiced would 
constitute an infiingement of any Patent, GTRC and MCGRI shall, subject to the pre-
existing rights of any third party, offer to CYBERCARE' the right of firSt Tefusaf to 
take up a license to make, sell or use such new invention within the Territory on terms 
and conditions to be negotiated. 
8. NEW DEVELOPMENTS 
8.1 Should GTRC or MCGRI make or discover any new invention which if practiced 
would not constitute an infringement of any Patent, but is in the Field ofTele-
Homecare, then, subject to the pre-existing rights · of any third party, GTRC and 
MCGRI shall offer to CYBERCARE the right of first refusal to take up a license to 
make, seU and use such new invention within the Territory on terms and conditions 
to be negotiated. ' · · · 
9. CONFIDENTIALID' 
9.1 CYBERCARE shall not disclose any Proprietary Information pertaining to the 
Invention other than to CYBERCARE employees or consultants who must have 
access to such Information in order to carry out CYBERCARE1S obligations under 
\ 
this Agreement and to potential sublicensees of the Technology, provided such 
disclosure is in accordance with Paragraph 9.3 hereof Prior to disclosure of 
Proprietary Wormation to CYBERCARE employees or consultants, such employees 
or consultants shall be under a 'Written obligation of confidentiality to CYBERCARE 
at least as restrictive as the provisions contained herein. Proprietary Information shall 
be maintained in con£dence by CYBERCARE for so long and to such extent as such 
Information is maintained in confidence by the Joint Owners. 
9.2 To protect the Joint Owners' Proprietary Information, CYBERCARE shall adopt 
security measures commonly observed in industries that rely on proprietary 
information. These measures shall include, but not be limited to, restricted access to 
such information, marking such information, and the selective destruction of sensitive 
materials. Upon termination oftrus Agreement, CYBERCARE shall return or destroy 
all documents or materials embodying the Jo~t Owners' Proprietary Information. 
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9.3 Any disclosure of Proprietary Infonnation by CYBERCARE to potential sublicensees 
of the Technology shall be prorubited, un1ess such potential sublicensee has signed an 
agreement which imposes obligations of confidentiality and nonuse at least as 
restrictive as those imposed on CYBERCARE hereunder. 
10. ThTIIAL DEVELOPMENT AND FULL USE OF TECHNOLOGY 
1 0.1 Demonstration units of the Electronic House Call System held by GIT or MCG will 
be made available to CXB,ERCAAE \Ulq~( . ,arm.ngem.ents, tQ be agreed .~een 
CYBERCARE and the Technical co·ntacts .for GTRC and MCGRI, as noted in 
Article 21.1 of this Agreement. 
10.2 As soon as reasonably practicable after the Effective Date of this Agreement, but not 
later than Eighteen (18) months after the Effective Date hereof, CYBERCARE shall 
take steps to meet the reasonable requirements of the market by offering for sale 
Products in sufficient quantities to meet a reasonable public demand. 
10 .. 3 ·CYBERCARE.shall, during eachofthe firsi Th.ee (3) years .from the Effective Date 
of this Agreement, provide to each of the Joint OWners at least Three Hundred and 
Fifty Thousand U.S. Dollars ($350,000) for further ~s~ch ~d. d~v~Jopm~ntin 
. connection Withthe Teehrio16gy. The sum '()fat'Jeast' Seven Thousand Five Hundred 
U.S. Dollars ($7,500) vvil1 be paid to each of the Joint Owners on the first (1st) 
business day of each of the three (3) caJendar months following the Effective Date 
of this Agreement as an advance payment on such funding. At the end of such three 
(3) months or on the execution of Basic Ordering Agreements in accordance with 
Anicle 1 0.4, payment of all costs of agreed Statements of Work, as referenced 
therein, shall be payable in accordance with the terms of such agreements. 
10.4 The further research and development to be undertaken in accordance with 
this Article shall be agreed periodically between CYBERCARE and the Joint 
Ovmers under subsequent Statements of Work, which shall be covered by Basic 
Ordering Agreements to be entered into respectively between CYBERCARE and 
GTRC, and CYBERCARE and MCGRI. The Basic Ordering Agreement and the first 
such Statements of Work with each of the Joint Owners will be agreed and entered 
into within Thirty (30) days from the Effective Date of this Agreement. The first of 
such Statements of Work for each succeeding License Agreement year shall be agreed 
and entered into within Thirty (30) days of each anniversary date of this License 
Agreement. The last of such Statements of Work satisfying the annual commitment 
for funding in accordance with this Article will be agreed and entered into within 
Eight (8) months of each such anniversary year. 
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10.5 Should funding for &alaries, fringe benefits and overheads be made available to GTRC 
or MCGRI by the Georgia Research Alliance, the U.S . Federal Government or other 
entities primarily as a result of a CYBERCARE initiative, such funding may be offset 
against CYBERCARE's commitment in accordance vvith Artide 10.3 herein. Should 
such funding be made available as a result of GTRC, GIT, MCGRI or MCG 
initiatives, and in the opinion of the GTRC and MCGRI nominees to the 
CYBERCARE Board ofDirectors, CYBERCARE made a significant contribution to 
the success of those initiatives, then a partial offset of such funds may be allowed as 
determined by the GTRC and MCGRI. 
10.6 Should GTRC not receive at least Fifty Thousand U.S. Dollars ($50,000) in royalty 
payments from CYBERCARE within Twenty-four (24) months from the Effective 
Date of this Agreement and shou1d GTRC not receive at least Two Hundred 
Thousand U.S. Dollars ($200,000) in royalty payments during each Twelve (12) 
month period thereafter for the term of this Agreement, GTRC shall have the option 
to terminate the license granted hereunder, to allow this Agreement to continue in full 
· force and effect or to convert the license granted hereunder to a nonexclusive license 
upon written notice to CYBERCARE. 
11. CONSULTING 
11.1 Any use of GIT or MCG personnel as consultants shall be on a noninterfering basis 
with nonnal GIT and MCG activities . CYBERCARE shall make arrangements 'With 
GIT and MCG to assure noninterference. Compensation and travel reimbursement 
are to be paid directly to consultants by CYBERCARE. The relationship between 
CYBERCARE and its consultants shall be outside the scope of this Agreement, 
exe;ept that such consulting agreements shall not under any circumstances grant 
CYBERCARE rights to any GIT/GTRC or MCGIMCGRI intellectual property. 
12. PROTECTION OF INTELLECTUAL PROPERIT 
12.1 GTRC shall fi.Je any and all patent applications, trademark registrations or copyright 
registrations (hereinafter "Intellectual Property Protection"), domestic and/or foreign, 
in the Joint Owner's names to protect the Techno1ogy and/or improvements to the 
Technology licensed hereunder. CYBERCARE shall have the right to fiJe such 
applications or registrations in GTRC's name, should GTRC fail to do so. 
CYBERCARE shall be responsible for all future costs, fees and expenses incurred in 
connection -with the filing, prosecution and maintenance of all Intellectual Property 
Protection and the maintenance of any patent, trademark or copyright issuing thereon, 
as long as the license rights granted herein remain exclusive. 
12.2 If patent, trademark or copyright protection is obtained for the Technology and/or 
improvements to the Technology, CYBERCARE shalJ cooperate with the Joint 
Owner's in enforcing or poucing such protection as provided in Article 13 herein and 
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by taking all appropriate measures including marking trade secrets and other 
Proprietary Information as required and taking other measures as mutually agreed to 
by GTRC and CYBERCARE. 
13. NOTICE OF INFRINGEMENT AND ENfORCEMEt{f OF RIGHTS 
13 .1 Imme&ately upon CYBERCARE's learning of any infringement, misappropriation or 
~ther ~~. use. ofth~ Jo.int Qwner'5 Proprietary lnfonnation; ~or Patents; · · 
oopynghts or trademarks pert8.inmg to the Joint Owners' Invention licensed hereunder 
(hereinafter "mtelJectual Property Rights"), CYBERCARE shall promptly inform 
GTRC. 
13.2 If CYBERCARE and the Joint Ovmers agree to jointly pursue enforcement of the 
Joint Owner's IntelJectual Property Rights, then CYBERCARE and GTRC shall share 
equally all costs, fees and/or expenses incurred in connection with enforcement of the 
Joint Owners' In.tellectual Property FJghts provided only that the GTRC's · maximum 
exposure for such costs, fees and expenses shall be the amount of royalties paid 
and/or payable to GTRC by CYBERCARE hereunder. Any payments accruing from 
such action ~o .ertfor~ ~he J()int O_wr:ter~'Intelle~ual . Property Rights shallbepaid to .. 
t'Y:B:ER.cARE and dtRt in proportion to the parties' respective contributions to all 
costs, fees and/or expenses incurred in such action. 
13.3 In the event that either party shall determine, for any reaso~ that it does not choose 
to enforce the Joint Owners' Intellectual Property Rights, then that party shall 
promptly notify the other party of such decision . The party choosing to enforce the 
Joint Owners' Intellectual Property R.jghts may then proceed with such enforcement 
action solely at its own expense and any and all recoveries shall be awarded solely and 
exclusively to that party. 
14 . Th"DEJ\fNID' 
14.1 CYBERCARE hereby indemnifies and holds harrn1ess GTRC, GIT, MCGRI, MCG, 
and the Board of Regents of the University System of Georgia, and their employees, 
officers, board members and agents (hereinafter "Indei1'UUteesn) from and against all 
c) aims, suits, liabilities, damages, costs, fees, expenses or losses arising out of or 
resulting from CYBERCARE's performance of this Agreement, including but not 
limited to any third party claims against the Indemnitees for patent, copyright, and/or 
trademark infringement and/or patent interference, and any damages, losses or 
liabilities whatsoever with respect to death or injury to any person and damage to any 
property arising from the possessio~ use or operation of Products produced or sold 
by CYBERCARE or its sublicensees or their customers in any manner whatsoever. 
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15. DISCLAIMER. WARRAND' AND LIMITATION OF LIABILITY 
15.1 EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, TIIE JOINT 
0\VNERS DISCLAIJvf ANY AND All. PRO:MJSES, REPRESENTATIONS AND 
WARRANTIES WITH RESPECT TO TilE TECHNOLOGY, INCLUDING ITS 
CONDffiON, CONFORMJTY TO ANY REPRESENTATION OR 
DESCRIPTION, THE EXISTENCE OF ANY LATENT OR PATENT DEFECTS 
1HEREIN AND ITS MERCHANT ABILITY OR FITNESS FOR A PARTICULAR 
USE OR PURPOSE. 
15:2 In no event ·shall theJoirit dvmers ·be liAble for ~Y use by CYBERCARE of the 
Technology or any loss, claim, damage or liability, of whatsoever kind or nature, 






Except for the purposes of identifying the Technology, no right, title, interest or 
license to any trademark or service mark, is granted to CYBERCARE. 
CYBERCARE shall during the term of this Agreement, as from the date of the first 
saJe ofProducts, maintain in full force and effect a product liability insurance policy 
in the amount of at least One Million U.S. Dollars ($1,000,000) and shall each year 
provide to GTRC evidence of such policy. 
18 RELATICb1'\SHIP BETWEEN THE JOINT OWNERS AND CYBERCARE 
18.1 The Joint Owners and CYBERCARE are and shall remain independent contractors 
and nothing herein shall create a partnership or joint venture between the Joint 
Owners and CYBERCARE. 
19. ADVERTISING. PUBLICIIT AND PUBLICATIONS 
19.1 Except as othenvise provided herein, CYBERCARE shall not use the names of 
Georg1a Tech Research Corporation, the Georgia Institute of Technology, Georgia 
Tech, the Georgia Tech Foundation, the Medical College of Georgia Research 
Institute, the Medical College of Georgia, or any of their respective affiliates or 
divisions in any advertisement or sales materials without the prior written consent of 
GTRC and MCGRI, wruch consent shall not be unreasonably withheld . 
19.2 In any pubucation (mcluding advertisements, sales and trade literature and instruction 
manuals) relating to the Invention used pursuant to this Agreement, CYBERCARE 
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shall, when appropriate, give due credit to the Joint Ovroers, as owners and licensors 
and in the case of professional journals, trade publications and editorials to the 
Inventors as shown in the Patents, as Inventors of the Invention. 
19.3 The Joint Owners and the Inventors shal1 have the right to publish papers and other 
scholarly materials on the Technology in the eppropriate literature. Such publication 
shall in no event disclose proprietary or confidential information of the other party. 
GTRC, GIT, MCGRI and MCG may catalog and place such publications in th~ GIT 
.and MCG hbraries. CYBERCARE shiill have the··nght to review materials relatecfto · . 
the Technology prior to publication. 
20. TERJ\1 Al\1J> TERMINATION 
20.1 This Agreement shall commence on the Effective Date of this Agreement and shall 
continue until the expiration of the last expiring patent covering any of the 
Technology licensed hereunder. 
20.2 In the event of the breach of a material obligation hereunder by either party, the 
non breaching party shall inform the alleged breaching party of said breach in writing. 
The alleged breaching party shall have sixty (60) days from the ·date of Sa.id 
notification during which time to cure the breach. In the event the aiieged breaching 
party does not cure the breach within sixty (60) days, the nonbreaching party may 
terminate the Agreement . 
20.3 CYBERCARE shall, within ten ( 1 0) days of termination of this Agreement for any 
rea_son, deliver to GTRC all written documentation in the possession of 
CYBERCARE which contains Proprietary Information pertaining to the Technology. 
20.4 Notwithstanding the foregoing, the obligations of the parties under Articles 5, 6, 9, 
13, 14, 15 and 20 shall survive any termination ofthis Agreement. 
21 . NOTICES 
21.1 All notices required or permitted under this Agreement shall be in vvriting and shall 
be delivered personally or sent by certi£ed registered mail to CYBERCARE or GTRC 
at the addresses set forth below: 
GTRC- For Administrative Matters: 
GEORGiA TECH RESEARCH CORPORATION 
Centennial Research Building 
Georgia Institute of Technology 
Atlanta, Georgia 30332-0415 
Ann Director, Technology Licensing 
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-For Technical Matters: 
Mr. Mchael F. Burrow, Acting Director 
Biomedical Interactive Technology Center 
Georgia Institute ofTechnology 
Atlanta, Georgia 30332-0823 
Dr. Max E. Stachura, Director 
·Center for Telemedicine . · · 
Medical College of Georgia 
Augusta, Georgia 30912-1655 
CYBERCARE: 
CYBERCARE, INC. 
430 Tenth Street, N.W. 
Suite S~004 . 
Atlanta, . Georgia 30318 
Attn: John Haines 
22 . WAnTIR 
22.1 Waiver by either party of any tenn or provision of this Agreement shall not constitute 
a continuing wruver thereof nor of any further or additional rights such party may hold 
under trus Agreement. 
\ 
23. SEVERABILITY 
23 .l If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, 
the validity, illegality or unenforceability of the remaining provisions shall not in any 
way be affected or impaired. 
24. GOVER""i'ING LA\\' 
24.1 This Agreement shall be construed in accordance with the laws of the State of 
Georgia, U.S.A. 
25. ENTIRE AGREEMENT 
25.1 This Agreement is the complete and excJusive statement between the parties relating 
to the subject matter hereo~ and supersedes all prior understandings, communications, 
or representations, either oral or written, between the parties. This License 
Agreement may not be modified or altered except by a written instrument duly 
executed by CYBERCARE and GTRC . 
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26. CUMULATIVE RIGHTS 
27. 
26 .1 Unless expressly stated to the contrary elsewhere in this Agreement, all rights, powers 
and privileges conferred hereunder upon the parties hereto shall be cumulative and not 
restrictive of those given by law. 
SECTION HEADINGS 
. . . ~ ... . ·. . . :· .. .. .. · ..... . . ... : .. . · . . .... . 
27.1 Section headings have been inserted herein for convenience of reference only and shall 
in no way modify or restrict any of the terms or provisions of this Agreement. 
28 . ASSIGNJ\fENT 
28.1 Subject -to this Paragraph, the ·License ispersonal to CYBERCARE. It is expressly . 
understood by." the parii~s that the L'icense may be. assigned . by GTRC to the Georgia 
Institute of Technology, the Medical College of Georgia or the Board of Regents of 
the University Syste_m ofthe_State 9[~o~gj-~. E~ce.pt ~ ot}le~se :•greed .. ~e.r~in, . .. 
'this Agreement 'may· not ·be. assigned .by either party without the prior written consent 
of the other. 
29 . SUCCESSORS AND ASSIGNS 
29.1 This Agreement shall bind and inure to the benefit of the parties hereto and their 
respective successors and permitted assigns, but nothing contained herein shall be 
deemed to permit assignment by either party except as otherwise permitted in this 
Agreement. 
30. INTERPRETATION 
3 0. 1 In the interpretation of this Agreement, words importing the singular or plural number 
shall be deemed to import the plural and singular number respectively, words denoting 
gender shall inc1ude all genders and references to persons shall include corporations 
or other bodies and vice versa. 
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31. FORCE MAJEURE 
31.1 Neither party shaii be held in breach of this Agreement because of acts or omissions 
caused by any act of God or other cause beyond the control of the parties, including, 
but not limited to, fire, floods, labor disputes, or other unforeseen circumstances. 
IN WITNESS WHEREOF, the parties have set their hands and _sea]s a.ndd~~y e;xecl1ted 
this_Agreement effective ·as of the date first· above Written.·= · "· · ·. · · · -
GEORGIA TECH R.ESEARCH..C'ORPORATION CYBERC.ARE, ~C . . 
By: __ Byt!- " 
Typed Name: J:,/,.. ~. 1/-. ,.~•J Typed Nare&rry Rosenberg \,./ 
Title: ~Technology Licensing Title: /re. s.tal..,r' ~ ce:o 
Date: _ __./_2-+-/-/ ~_,_;;_,_'7---.:. ?~~------' -Date: · . · .. :.-:-... -l'L-/tt./f-7-
By: ____ 
0
...,t..t....:.. . _-:;._-_ ____;-.~:...-....~G:;..._-.....;-~r=- -
Typed Name:_J_.W_. D_e_e_s _____ _ 
As'st Secretary 
Title : ____________ _ 
Date: '""/tt. /tz 
--------~~,~~-------
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